ResMed settles licensing, patent spat for $25M

August 19, 2013 by Brad Perriello

ResMed settles a licensing and patent infringement dispute with Australia's University of Sydney for $25 million.

ResMed settles licensing, patent spat for $25M

ResMed (NYSE:RMD) said it paid a total of $25 million to settle a lawsuit filed in Australia by the University of Sydney accusing it of breaking a licensing deal and patent infringement.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp